Lungs Channel
Topics & Medications
Quicklinks
Related Channels
Generic Accolate
The first patent for Accolate (zafirlukast) has expired, and generic versions are now available. All of the generic versions of Accolate are considered equivalent to the brand-name drug. However, generic medications may contain different inactive ingredients, such as fillers or dyes, that could cause problems for people with certain sensitivities.
Accolate® (zafirlukast) is a prescription medication used to prevent asthma attacks. It is part of a group of medications called leukotriene modifiers.
Brand-name Accolate is manufactured by AstraZeneca Pharmaceuticals. However, the first patent for Accolate expired in September 2010, and a generic version is now available.
Generic Accolate tablets are available in the following strengths:
- Zafirlukast 10 mg
- Zafirlukast 20 mg.
Generic Accolate is made by Dr. Reddy's Laboratories.
All generic medications must undergo certain tests to compare them to brand-name medications. The U.S. Food and Drug Administration (FDA) then looks at these tests to decide if the generics are equivalent to the brand-name medications and assigns a rating to each one.
An "AB" rating means that the FDA has determined that a generic medication is equivalent to a brand-name medication. Generic zafirlukast has an "AB" rating, meaning it should be equivalent to Accolate.
However, generic medications are allowed to have different inactive ingredients than the brand-name medication. This might include fillers, dyes, or other ingredients that may cause problems for people with allergies or sensitivities.
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD